Pfizer to Pay Up to $250m to Settle Some Zantac Cancer Suits: FT

Pfizer has agreed to pay between $200m to $250m to settle more than 10,000 US lawsuits over cancer risks associated with Zantac, Financial Times reports, citing two unidentified people briefed on the deal.

• Pfizer said it continues to “vigorously defend against Zantac lawsuits, which we believe are not supported by reliable science”: FT
  • Co has explored and will continue to explore “opportunistic settlements of certain cases if appropriate” and has settled some cases
• NOTE: Pfizer Agrees to Settle More than 10,000 Zantac Cancer Suits

To view the source of this information, click here

To contact the reporter on this story: ...